Comparison of the clinical efficacy and safety of salmeterol/fluticasone propionate versus current care in the management of persistent asthma in Korea

Author： Jung Ki-Suck   Uh Soo-Taek   Lee Yong-Chul   Shim Jae-Jeong   Park Soon-Kew   Williams Angela E.   Chan Robert  

Publisher： Informa Healthcare

E-ISSN： 0300-7995|24|12|3571-3582

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.24, Iss.12, 2008-12, pp. : 3571-3582

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Combination Therapy with the Single Inhaler Salmeterol/Fluticasone Propionate versus Increased Doses of Inhaled Corticosteroids in Patients with Asthma

By  

Respiration, Vol. 74, Iss. 1, 2006-09 ,pp. : 33-43

Karger

Access to resources Recommend Favorite

Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids

By Friedman Howard S.   Yawn Barbara P.  

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 427-434

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of salmeterol xinafoate/fluticasone propionate combination inhaler in chronic asthma

By Doull Iolo   Price David   Thomas Mike   Hawkins Neil   Stamuli Eugena   Tabberer Maggie   Gosden Toby   Rudge Helen  

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 1147-1159

Informa Healthcare

Access to resources Recommend Favorite

Asthma exacerbations in African Americans treated for 1 year with combination fluticasone propionate and salmeterol or fluticasone propionate alone

By Bailey William   Castro Mario   Matz Jonathan   White Martha   Dransfield Mark   Yancey Steve   Ortega Hector  

Current Medical Research and Opinion, Vol. 24, Iss. 6, 2008-06 ,pp. : 1669-1682

Informa Healthcare

Access to resources Recommend Favorite

An observational study of fixed dose combination fluticasone propionate/salmeterol or fluticasone propionate alone on asthma-related outcomes**

By Stanford Richard H.   Fuhlbrigge Anne   Riedel Aylin   Rey Gabriel Gomez   Stempel David A.  

Current Medical Research and Opinion, Vol. 24, Iss. 11, 2008-11 ,pp. : 3141-3148

Informa Healthcare

Access to resources Recommend Favorite